During the past decade, Michigan Heart conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 16 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan Heart" #1 sponsor was "Medtronic" with 7 trials, followed by "Biotronik, Inc." with 4 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "C. R. Bard" with 2 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Heart" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Heart" are "Heart Failure" (9 trials), "Bradycardia" (3 trials), "Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Michigan Heart" in a lesser frequency.

Most popular intervention types in "Michigan Heart" are "Device" (15 trials), "Drug" (14 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Micra Pacemaker Implant" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials) and "BO-653" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Heart" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Heart". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Michigan Heart, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Heart, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".

Michigan Heart has several departments that took part in Clinical trials: "Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus" - 169 trials, "Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital" - 168 trials, "Trinity Health IHA Medical Group Hematology Oncology - Brighton" - 167 trials, "Trinity Health IHA Medical Group Hematology Oncology - Canton" - 167 trials, "IHA Chelsea Family & Internal Medicine" - 4 trials, "Trinity Health-Michigan d/b/a Michigan Heart" - 3 trials, "IHA Internal Medicine - Domino's Farms" - 2 trials